ScienceSTORY FILE
Lithuanian company, ESA complete space medicine experiment for ISS launch
Lithuanian biotechnology company Delta Biosciences and the European Space Agency (ESA) have completed final integration of an experiment designed to determine how space radiation affects medicines, clearing the payload for a planned December launch to the International Space Station.
There’s more to the story.
You’re reading material shared in LRT Lithuania’s RSS feed. Continue with the original publisher for the complete story.
Continue at LRT LithuaniaOriginal reporting remains with its publisher.Back to the edition